Ten years after its debut, the World Bronchiectasis Conference (WBC) returned to where it all began: From 24 to 27 June 2026, the 9th World Bronchiectasis Conference took place at the Hannover Congress Centrum. Alongside the European Bronchiectasis Registry EMBARC, the Hannover site of the German Center for Lung Research (BREATH), Hannover Medical School (MHH), and the CAPNETZ STIFTUNG, the German Bronchiectasis Registry PROGNOSIS was among the conference’s co-organizers.
With 1,334 participants from 63 countries, this year’s WBC was the largest international conference to date dedicated exclusively to bronchiectasis. A total of 153 invited speakers and 217 submitted abstracts also highlighted the remarkable progress made in bronchiectasis research in recent years.
Two renowned German bronchiectasis experts and members of the PROGNOSIS Executive Board, Prof. Dr. Jessica Rademacher and Prof. Dr. Felix C. Ringshausen, served as Co-Chairs and helped shape the scientific programme of the conference. Numerous additional contributions from the German research network reflected the importance of bronchiectasis research in Germany.
There was also reason to celebrate for an early-career researcher from Hannover: Meret Moormann, a medical student at MHH and doctoral researcher in the Department of Respiratory Medicine and Infectious Diseases, received one of the conference’s poster awards. In her presentation entitled “Serum Club Cell Protein 16 (CC16) and its Association with Bronchiectasis Severity and Activity – Data from the German Bronchiectasis Registry PROGNOSIS”, she investigated the association between serum CC16 levels and bronchiectasis severity and disease activity. Her analysis was based on data from the PROGNOSIS Registry.
“Registries such as PROGNOSIS are immensely valuable for bronchiectasis research because they enable us to better understand disease trajectories, identify relevant biomarkers, and develop new research questions directly from clinical practice,” says Prof. Dr. Felix C. Ringshausen.
Another highlight of the conference was the inaugural presentation of the Tobias Welte Award, recognising outstanding contributions to bronchiectasis research and patient care. Tobias Welte initiated the first WBC in Hannover in 2015 and was among the co-founders of EMBARC and PROGNOSIS. “Tobias Welte played a pivotal role in shaping bronchiectasis research in Germany, Europe, and beyond. He recognised early on how crucial international collaboration and joint registries were for advancing research into this previously neglected disease,” says Prof. Dr. Jessica Rademacher, whose scientific career was closely supported and guided by Tobias Welte over many years. The first recipient of the award was Professor Lucy Burr from Brisbane, Australia.
The WBC 2026 clearly demonstrated how much the international bronchiectasis community has grown over the past decade. For PROGNOSIS, the conference also provided an important platform to highlight the value of registry-based research and to generate new momentum for future scientific collaboration.
Detailed article in Pneumologie
Text: BREATH/AB

Prof. Dr. Felix Ringshausen presents doctoral researcher Meret Moormann with the poster award.